Myths vs facts: CYP2C19 and Abnehmen

CYP2C19 is a liver enzyme primarily involved in drug metabolism (e.g., clopidogrel, proton pump inhibitors). There is no strong scientific evidence directly linking CYP2C19 variants to weight loss. Some mechanistic studies suggest possible minor influences on fatty acid or hormone metabolism, but the effects are small and clinically insignificant. Claims that CYP2C19 determines weight loss success are largely myths. Weight management depends on calorie balance, physical activity, and overall diet – not this gene. Evidence: weak mechanistic, no robust human trials. Caveat: direct-to-consumer genetic tests often overstate such associations.